Hematopoietic prostaglandin D synthase inhibitors for the treatment of inflammatory disorders

被引：0
|
作者：
Thurairatnam, Sukanthini [1 ]
机构：
[1] Sanofi Pharmaceut, Bridgewater, NJ 08807 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2012年 / 244卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
11-MEDI
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Crystal Structure of Hematopoietic Prostaglandin D Synthase Complexed of HQL-79
    Kado, Yuji
    Inoue, Tsuyoshi
    Aritake, Kousuke
    Katsuyama, Naoko
    Matsumura, Hiroyoshi
    Urade, Yoshihiro
    Kai, Yasushi
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2005, 61 : C348 - C349
  • [32] Molecular Recognition Mechanism of Hematopoietic Prostaglandin D Synthase with Cofactor and its Substrate
    Shimamoto, Shigeru
    Asada, Keisuke
    Hidaka, Yuji
    BIOPHYSICAL JOURNAL, 2018, 114 (03) : 581A - 581A
  • [33] Therapeutic Potential of Hematopoietic Prostaglandin D2 Synthase in Allergic Inflammation
    Rittchen, Sonja
    Heinemann, Akos
    CELLS, 2019, 8 (06)
  • [34] Discovery of an Oral Potent Selective Inhibitor of Hematopoietic Prostaglandin D Synthase (HPGDS)
    Carron, Chris P.
    Trujillo, John I.
    Olson, Kirk L.
    Huang, Wei
    Hamper, Bruce C.
    Dice, Tom
    Neal, Bradley E.
    Pelc, Matthew J.
    Day, Jacqueline E.
    Rohrer, Douglas C.
    Kiefer, James R.
    Moon, Joseph B.
    Schweitzer, Barbara A.
    Blake, Tanisha D.
    Turner, Steve R.
    Woerndle, Rhonda
    Case, Brenda L.
    Bono, Christine P.
    Dilworth, Vickie M.
    Funckes-Shippy, Christie L.
    Hood, Becky L.
    Jerome, Gina M.
    Kornmeier, Christine M.
    Radabaugh, Melissa R.
    Williams, Melanie L.
    Davies, Michael S.
    Wegner, Craig D.
    Welsch, Dean J.
    Abraham, William M.
    Warren, Chad J.
    Dowty, Martin E.
    Hua, Fengmei
    Zutshi, Anup
    Yang, Jerry Z.
    Thorarensen, Atli
    ACS MEDICINAL CHEMISTRY LETTERS, 2010, 1 (02): : 59 - 63
  • [35] Kinase inhibitors for the treatment of inflammatory and autoimmune disorders
    Shripad S. Bhagwat
    Purinergic Signalling, 2009, 5
  • [36] Kinase inhibitors for the treatment of inflammatory and autoimmune disorders
    Bhagwat, Shripad S.
    PURINERGIC SIGNALLING, 2009, 5 (01) : 107 - 115
  • [37] PROSTAGLANDIN SYNTHASE INHIBITORS IN PRETERM LABOR
    VANKETS, H
    THIERY, M
    DEROM, R
    VANEGMOND, H
    BAELE, G
    LANCET, 1980, 2 (8196): : 693 - 693
  • [38] Prostaglandin H synthase-2 inhibitors interfere with prostaglandin H synthase-1 inhibition by nonsteroidal anti-inflammatory drugs
    Rosenstock, M
    Danon, A
    Rubin, M
    Rimon, G
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 412 (01) : 101 - 108
  • [39] In silico prediction of prostaglandin D2 synthase inhibitors from herbal constituents for the treatment of hair loss
    Fong, Pedro
    Tong, Henry H. Y.
    Ng, Kin H.
    Lao, Cheng K.
    Chong, Chon I.
    Chao, Chi M.
    JOURNAL OF ETHNOPHARMACOLOGY, 2015, 175 : 470 - 480
  • [40] Identification of new inhibitors for human hematopoietic prostaglandin D2 synthase among FDA-approved drugs and other compounds
    Mazari, Aslam M. A.
    Hegazy, Usama M.
    Mannervik, Bengt
    CHEMICO-BIOLOGICAL INTERACTIONS, 2015, 229 : 91 - 99
12345